West Pharmaceutical Services (WST) Finished Goods (2010 - 2012)

West Pharmaceutical Services' Finished Goods history runs 3 years deep, the most recent figure standing at $65.3 million for Q2 2012.

• In Q2 2012, Finished Goods fell 9.18% year-over-year to $65.3 million; the TTM figure through Jun 2012 stood at $65.3 million (down 9.18% YoY), while the FY2011 annual figure was $67.1 million, up 3.07% from the prior year.
• Finished Goods came in at $65.3 million for Q2 2012 at West Pharmaceutical Services, down from $67.1 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $71.9 million in Q2 2011 to a low of $65.1 million in Q4 2010.
• A 3-year average of $67.7 million and a median of $67.1 million in 2011 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods rose 3.07% in 2011 and decreased 9.18% in 2012, its largest moves.
• West Pharmaceutical Services' Finished Goods stood at $65.1 million in 2010, then grew by 3.07% to $67.1 million in 2011, then slipped by 2.68% to $65.3 million in 2012.
• According to Business Quant data, Finished Goods over the past three periods registered $65.3 million, $67.1 million, and $68.9 million for Q2 2012, Q4 2011, and Q3 2011 respectively.

Peer Comparison